Resveratrol directly targets COX-2 to inhibit carcinogenesis.
about
Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular DiseasesResveratrol and cancer: Challenges for clinical translationUnraveling the Anticancer Effect of Curcumin and ResveratrolGrowth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells In VitroResveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.Epigenetics: A New Bridge between Nutrition and Health.Many putative endocrine disruptors inhibit prostaglandin synthesis.Pleiotropic mechanisms facilitated by resveratrol and its metabolites.Resveratrol-sensitized UVA induced apoptosis in human keratinocytes through mitochondrial oxidative stress and pore openingBioactive food components, inflammatory targets, and cancer prevention.Resveratrol as a calorie restriction mimetic: therapeutic implications.When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Natural Agents Used in Chemoprevention of Aerodigestive and GI CancersResveratrol: Biological and pharmaceutical properties as anticancer molecule.Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.Natural products and colon cancer: current status and future prospects.Functional/activity network (FAN) analysis of gene-phenotype connectivity liaised by grape polyphenol resveratrol.Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging.Resveratrol oligomers for the prevention and treatment of cancers3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.Natural polyphenols in cancer therapy.Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.Mechanisms of action of phenolic compounds in olive.Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.Resveratrol may improve osseointegration of dental implants in type 2 diabetes mellitus patients.Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms.Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation.Polyphenols in Health and Disease.Resveratrol as a supplemental treatment for periodontitis.Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.Developing a CoMSIA Model for Inhibition of COX-2 by Resveratrol Derivatives.Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics.Lignin-derived oak phenolics: a theoretical examination of additional potential health benefits of red wine.Low-dose dietary resveratrol has differential effects on colorectal tumorigenesis in adiponectin knockout and wild-type mice.Protective and Restorative Effects of Nutrients and Phytochemicals.
P2860
Q26767400-D9F2F5F9-5035-4A20-AB8D-3D259B74F999Q27015712-FE1E0AE6-CF91-4C73-B9E1-DA42D44F7C26Q28073155-52C19224-7CBA-47C5-818C-6F5F922C9E6FQ28818518-65B45657-1530-499B-BED0-B1A382840D55Q30009351-77F8D04B-3434-4D5C-ABEF-B74606B60696Q30994649-306C72F3-8889-4B2B-84C7-40FBB639399EQ33710807-A02AA829-D888-4594-9D81-7F6A5C035C72Q33750847-AB99663E-64F7-4882-9055-C9C7A92FEE15Q34104944-A38295CE-7A4C-4A12-9304-07E0AE50C91EQ34591910-2A4AC50B-106E-4575-AA16-B59D3BAE7827Q34834713-63A2F1B2-7D58-40DB-8D10-11F051ADCF94Q35692517-A11B3829-7BB0-42CE-916D-A929A199F343Q36088806-E612B790-98D7-45D3-9622-E4829A656B05Q36254183-F17819DC-0E9C-4403-9924-1DB6657FCB45Q36291200-9DEFE199-CA7E-4D5E-975E-AA285090AE19Q36442945-BE010634-F7CB-4FF6-A813-3727B55A5BF0Q36843653-BE843AFE-5F12-4205-B966-70473E7FA446Q36848141-1FBD6B3B-58A2-4371-B8BC-2F7FFFBA716CQ36956879-126FEAFC-7A87-41AD-A14A-D458BCCAFC03Q37136990-CB7B6411-14B7-45D5-9909-5B4BBDA69C52Q37437626-BCC0E2F3-DD50-4741-9F8C-E5EA94F8909BQ37629176-5A2D22C5-B338-4C94-80A8-556B89918C1EQ37706275-51F3C0A0-C54B-41FD-BA1C-BC4F0A6420C2Q37735173-F070B1F4-201C-47C9-9B02-340833368A8FQ37964733-919FC136-71E5-4987-95C1-16F434DAA55CQ38010202-DBBE2C55-718E-42C3-9EA3-B00677430F87Q38011271-8A566750-DECC-456D-80AB-E6FAFFA8550DQ38262594-1EBD0AAF-F356-41BA-9A4C-C2C8ADB4FDC0Q38426027-6643476D-F6B0-4850-A5C3-B27F0C9BF78DQ38534570-F4E576F6-B89F-4A06-83F3-44BC674B9632Q38550350-36881E36-91FF-42DB-ABE7-3B53338C5C65Q38853155-3F1ED996-32D7-4023-B381-2108E5FA5C7FQ39439300-BCF121D0-893D-4A51-8BC7-B359BFF02A13Q39643271-3C874EA5-C008-4F80-AF27-DBD36F69B0A1Q40144743-42898455-BD9B-4BF6-A23D-55ED36FB8AABQ42355112-6523B1AA-A72F-473D-8D84-613D97DCA08EQ47215081-500CE1D4-84A5-4542-A8FD-D0AD53C3DC16Q50554887-4CAA95FC-A500-49DC-AEA5-26A7C4D89478Q51407929-58D1D67E-EF31-4934-BC69-B1876A865C04Q53821180-20FD8D43-D668-4B00-938B-4D9649D59479
P2860
Resveratrol directly targets COX-2 to inhibit carcinogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Resveratrol directly targets COX-2 to inhibit carcinogenesis.
@en
type
label
Resveratrol directly targets COX-2 to inhibit carcinogenesis.
@en
prefLabel
Resveratrol directly targets COX-2 to inhibit carcinogenesis.
@en
P2093
P2860
P356
P1476
Resveratrol directly targets COX-2 to inhibit carcinogenesis
@en
P2093
Ann M Bode
Ki Won Lee
Svetlana P Ermakova
Tatyana A Zykova
Xiuhong Zhai
Zigang Dong
P2860
P304
P356
10.1002/MC.20437
P50
P577
2008-10-01T00:00:00Z